FDA approves selpercatinib for RET fusion-positive medullary thyroid cancer

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-selpercatinib-ret-fusion-positive-medullary-thyroid-cancer?utm_medium=email&utm_source=govdelivery